福建地區(qū)107例重癥藥疹臨床分析
[Abstract]:Objective: to investigate the prevalence and clinical characteristics of severe drug eruption in Fujian province by analyzing the clinical data of 107 patients with severe drug eruption. Methods: from 2010 to 2012, 107 patients with severe drug rash were admitted from the first affiliated Hospital of Fujian Medical University, the first Hospital of Quanzhou City and the first Hospital of Xiamen City. All the subjects met the diagnostic criteria. Inclusion criteria The classification of severe drug eruption, sensitizer, sex, age, incubation period were described. The sex and age of SCDR patients caused by different sensitizers were analyzed by nonparametric test. The results of related laboratory tests of different types of SCDR patients were tested by independent samples, and the correlation between the results of related laboratory tests and the dose of control hormone was analyzed by using the bivariate method. Finally, the relationship between multiple factors and prognosis was analyzed by multi-classification logistic method. Results: from 2010 to 2012, the number of male patients with severe drug rash was slightly higher than that of female patients in three hospitals of Fujian province, the ratio of male to female was 1.18: 1, and the number of patients with severe drug rash increased year by year in the past three years, among which SJS patients were the most common. Antibiotics are the most common drugs causing severe drug rash in Fujian area. The others are antiepileptic and psychoactive drugs allopurinol Chinese medicine and patent medicine antipyretic analgesics. However, there was no significant difference in the sex distribution of severe drug rash caused by different sensitizers (P0.05), while the average age of patients with severe drug eruption induced by allopurinol was longer than that of other patients (P0.05). The latency of DIHS was the longest in type 3 severe drug rash. AST elevation is most common in patients with severe drug rash. In the three types of drug rash, the abnormality of ALT EW BC in DIHS was more obvious than that in other types of drug rash, and the difference was statistically significant (P0.05), while the increase of NE% in TEN was more significant than that in other two types of severe drug rash (P0.05). However, the elevation of creatinine in allopurinol was more obvious than that in other drugs (P0.05). However, the incidence of mucosal involvement was directly proportional to the dose of control hormone (R value 0), and had significant statistical significance (P0.05). Sex, age, creatinine, urea nitrogen and control hormone dose were not significantly correlated (P0.05). Age bun was associated with the prognosis. The older the age, the higher the bun level, the worse the prognosis. Conclusion 1. The incidence of severe drug rash in Fujian Province is on the rise, and the main sensitizing drugs are antibiotics, antiepileptic and psychotic, allopurinol. 2. Severe drug rash caused by allopurinol is more. 3. 3 years old than that caused by other drugs. In severe drug rash, the increase of AST was most common, and the abnormality of AST in DIHS patients was more obvious than that in other types of drug rash. In TEN patients with severe drug rash induced by allopurinol, renal dysfunction was more common than that caused by other drugs. The older the age, the higher the bun value, the worse the prognosis.
【學位授予單位】:福建醫(yī)科大學
【學位級別】:碩士
【學位授予年份】:2015
【分類號】:R758.25
【相似文獻】
相關期刊論文 前10條
1 畢偉麗,鄭建華;藥物致敏與重癥藥疹的分析[J];黑龍江醫(yī)學;2001年07期
2 李茂玉;重癥藥疹的護理[J];職業(yè)衛(wèi)生與病傷;2002年03期
3 肖異珠,王華;兒童重癥藥疹22例臨床分析[J];兒科藥學雜志;2004年06期
4 錢奕紅,羅靜,陶小華;重癥藥疹32例臨床分析[J];中國現(xiàn)代應用藥學;2005年04期
5 劉太華;許澤娟;張忠奎;羅陳;;重癥藥疹3例及救治[J];藥物流行病學雜志;2006年02期
6 胡成;吳建華;顧軍;;重癥藥疹24例臨床分析[J];中國皮膚性病學雜志;2006年11期
7 牛紅喜;耿龍;尚英彬;徐媛媛;宋芳吉;;21例重癥藥疹死亡臨床分析[J];中國麻風皮膚病雜志;2006年12期
8 王秋艷;;重癥藥疹19例臨床分析[J];中國醫(yī)藥導報;2007年12期
9 巫毅;王雪峰;李曉天;李雪萍;;同患兩型重癥藥疹死亡1例[J];中國麻風皮膚病雜志;2007年04期
10 唐改枝;;老年人重癥藥疹的護理體會[J];中國社區(qū)醫(yī)師(醫(yī)學專業(yè)半月刊);2009年20期
相關會議論文 前10條
1 劉小筠;勞力民;;合并眼損害的重癥藥疹臨床特點分析[A];中華醫(yī)學會第16次全國皮膚性病學術年會摘要集[C];2010年
2 尹光文;;重癥藥疹的診斷和鑒別診斷[A];中華醫(yī)學會第十八次全國皮膚性病學術年會論文匯編[C];2012年
3 李秋紅;張東;;重癥藥疹16例護理體會[A];中華護理學會全國第6屆重癥監(jiān)護護理學術交流暨專題講座會議論文匯編[C];2009年
4 李虹;;重癥藥疹的臨床研究[A];2010全國中西醫(yī)結合皮膚性病學術會議論文匯編[C];2010年
5 陳小玫;程燕;郭在培;張敏;;合并嚴重皮膚感染的重癥藥疹治療分析[A];2010全國中西醫(yī)結合皮膚性病學術會議論文匯編[C];2010年
6 劉君麗;;重癥藥疹16例的護理體會[A];2011全國中西醫(yī)結合皮膚性病學術會議論文匯編[C];2011年
7 李鐵男;劉巖;;重癥藥疹治療方面的感悟和思考[A];2011全國中西醫(yī)結合皮膚性病學術會議論文匯編[C];2011年
8 陳忠英;;淺談重癥藥疹[A];中華醫(yī)學會第14次全國皮膚性病學術年會論文匯編[C];2008年
9 安媛媛;;重癥藥疹的護理[A];2012全國中西醫(yī)結合皮膚性病學術會議論文匯編[C];2012年
10 楊小英;韓宇陽;;62例兒童住院重癥藥疹臨床回顧[A];中華醫(yī)學會第十八次全國皮膚性病學術年會論文匯編[C];2012年
相關重要報紙文章 前3條
1 韓詠霞;四類藥物易誘發(fā)重癥藥疹[N];大眾衛(wèi)生報;2009年
2 羅剛 馬鳳琴;抗生素和抗癲癇類藥物誘發(fā)重癥藥疹比例較高[N];健康報;2006年
3 記者 喬寧;別嘌醇易致重癥藥疹等不良反應[N];健康報;2013年
相關碩士學位論文 前10條
1 許軒齊;大皰表皮壞死松解型藥疹使用靜脈注射丙種球蛋白的系統(tǒng)回顧與薈萃分析[D];山東大學;2015年
2 邱建文;重癥藥疹69例臨床回顧性分析[D];昆明醫(yī)科大學;2015年
3 申卉;重癥藥疹85例臨床分析[D];重慶醫(yī)科大學;2015年
4 胡信林;福建地區(qū)107例重癥藥疹臨床分析[D];福建醫(yī)科大學;2015年
5 劉小筠;合并眼損害的重癥藥疹臨床特點分析[D];浙江大學;2010年
6 張峰;52例重癥藥疹臨床回顧性分析[D];華中科技大學;2006年
7 于鵬;25例重癥藥疹的臨床分析[D];大連醫(yī)科大學;2014年
8 汪小柳;重癥藥疹36例臨床回顧性分析[D];浙江大學;2009年
9 方曉;兒童重癥藥疹51例臨床特征分析[D];重慶醫(yī)科大學;2012年
10 阮振強;48例重癥藥疹患者的臨床回顧性分析[D];新疆醫(yī)科大學;2014年
,本文編號:2178908
本文鏈接:http://sikaile.net/yixuelunwen/pifb/2178908.html